Carlyle Group To Buy J&J's Ortho-Clinical Diagnostics Business For $4.15 Bln

(RTTNews) - Global alternative asset manager The Carlyle Group (CG) said Thursday that it has agreed to acquire Johnson & Johnson's (JNJ) Ortho-Clinical Diagnostics or OCD business, a global provider of solutions for screening, diagnosing, monitoring and confirming diseases, for $4.15 billion.

The transaction is subject to customary regulatory approvals and is expected to close in the middle of 2014.

Separately, Johnson & Johnson confirmed that it has received a binding offer from The Carlyle Group to acquire its Ortho-Clinical Diagnostics business for $4.15 Billion.

The acceptance period for the offer will end on March 31, 2014, unless extended, and during that time Johnson & Johnson will consult with relevant works councils and trade unions. If the offer is accepted by Johnson & Johnson, the proposed transaction would be expected to close toward the middle of the year, pending fulfillment of certain conditions, including, but not limited to, the receipt of applicable anti-trust clearances and other customary closing requirements.